Quest Diagnostics Acquires LifeLabs from OMERS for CAN$1.35B
July 8, 2024
Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.
- Buyers
- Quest Diagnostics
- Targets
- LifeLabs
- Sellers
- OMERS
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Quest Diagnostics Acquires Labtech Diagnostics
December 14, 2021
Healthcare Services
Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.
-
Dynacare (a Labcorp company) Acquires Valley Medical Laboratories
May 1, 2023
Healthcare Services
Dynacare, a Labcorp subsidiary, has agreed to acquire Valley Medical Laboratories effective May 1, 2023. The acquisition adds Valley Medical’s network of 14 patient service locations and more than 150 staff in the Okanagan Valley, expanding Dynacare’s diagnostic and community laboratory presence in British Columbia.
-
Quest Diagnostics Acquires Haystack Oncology
April 27, 2023
Healthcare Services
Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.
-
Labcorp Acquires Certain BioReference Health Laboratory Assets for $237.5M
March 28, 2024
Healthcare Services
Labcorp will acquire certain laboratory testing businesses and operating assets from Opko Health subsidiary BioReference Health for $237.5 million. The assets — which generate roughly $100 million in annual revenue — include patient service centers and select customer contracts across the U.S. (excluding New York and New Jersey); BioReference Health will retain its oncology and urology diagnostic businesses and full operations in New York and New Jersey. The transaction is expected to close in the second half of 2024, subject to customary conditions and regulatory approvals.
-
Fountain Life Acquires LifeOmic
December 6, 2023
Healthcare Services
Fountain Life, a preventative health and advanced diagnostics membership company, has acquired LifeOmic, a health data technology firm, obtaining LifeOmic's platform, mobile apps, IP, and engineering team to power Fountain Life's data-driven diagnostics and membership services. The acquisition will integrate LifeOmic's cloud data, genomic analysis, EHR integration, and AI/ML capabilities into Fountain Life's digital and at-home offerings to expand its precision and preventive care services.
-
Atairos Acquires LifeLabs Learning
March 24, 2023
Education
Atairos, an independent strategic investment company, acquired LifeLabs Learning, a provider of manager and team upskilling programs, in a transaction that closed on March 23, 2023. The investment will accelerate LifeLabs Learning’s rollout of digital learning innovations and support growth of its manager-focused training programs; Houlihan Lokey served as exclusive financial advisor to Atairos.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.